The Medical Advisor

Introduction There is increasing interest in the potential use of Ivermectin and Fenbendazole as cancer treatments. This guide compiles key resources—including research articles, protocols, and expert insights—exploring their possible roles in cancer therapy. Several case reports for fenbendazole, ivermectin and mebendazole have revealed promising effects of these drugs in human patients having variable types of cancers.  The present paper aimed to review recent trends in use of ivermectin, fenbendazole and mebendazole as new promising anti-cancer agents.   Ivermectin: Key Resources Ivermectin is one of the top non-standard or non-conventional drug for cancer. Informative Article and Videos June 10, 2024  - "15 minutes with Dr.Makis" - Episode 018: High Dose IVERMECTIN and CANCER 2024 Studies Baghli et al 2024 -  Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: ...

Executive Summary Dr. Thomas N. Seyfried , Professor of Biology at Boston College, proposes a metabolic model of cancer that challenges the dominant genetic explanation and conventional oncology treatments. Rather than viewing cancer as primarily driven by gene mutations, Seyfried asserts it is fundamentally a metabolic disease centered on dysfunctional cellular energy production. This reframing draws on and expands the historical Warburg effect , emphasizing how cancer cells rely on fermentative metabolism of glucose and glutamine due to defective mitochondrial function.  A 2026 large-scale population study published in Nature Communications demonstrated that machine learning-predicted insulin resistance was associated with increased risk of 12 cancer types in nearly 500,000 individuals from the UK Biobank. This finding strengthens a growing thesis: Metabolic dysfunction is not merely a comorbidity — it may be a central modifiable axis in oncogenesis. Standard of Care: T...